An alternate pathway for type 1 T cell differentiation.

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

An alternate pathway for type 1 T cell differentiation.

Int Immunol. 1999 Aug;11(8):1185-94. Unique Identifier : AIDSLINE MED/99352249
Feng C; Watanabe S; Maruyama S; Suzuki G; Sato M; Furuta T; Kojima S; Taki S; Asano Y; Department of Microbiology and Immunology, Ehime University; School of Medicine, Shigenobu, Ehime 791-0295, Japan.

Abstract: IFN-regulatory factor-1 (IRF-1) gene-disrupted mice are defective in IL-12 and IL-18 gene expression at the transcriptional and post-translational level respectively. The mutant mouse mounts a type 2 T cell response upon bacterial infection because of the impaired induction of the IL-12 p40 gene and IFN-gamma-producing type 1 T cells are not induced. We showed here, however, that different pathogens activate a novel pathway for inducing IFN-gamma-producing type 1 T cells even in an IRF-1-deficient mouse. This pathway is independent of IL-12 and IL-18, and is mediated by a distinct function of macrophage lineage cells. Macrophages of the mutant mice fail to activate the IL-12-dependent pathway, but they function in the IL-12-independent pathway in Plasmodium-infected mice. This leads to the hypothesis that the IL-12-independent novel pathway for inducing IFN-gamma-producing T cells is distinct from the classical type 1/type 2 T cell subset differentiation pathway.

Keywords: JOURNAL ARTICLE Animal Cell Differentiation DNA-Binding Proteins/GENETICS/*METABOLISM Enzyme-Linked Immunosorbent Assay Gene Expression Regulation Interferon Type II/*BIOSYNTHESIS Interleukin-12/GENETICS/*METABOLISM Interleukin-18/GENETICS/METABOLISM Leishmania major/IMMUNOLOGY Leishmaniasis, Cutaneous/IMMUNOLOGY Listeria Infections/IMMUNOLOGY Macrophages, Peritoneal/*IMMUNOLOGY Malaria/IMMUNOLOGY Mice Mice, Inbred BALB C Mice, Inbred C57BL Phosphoproteins/GENETICS/*METABOLISM Plasmodium berghei Reverse Transcriptase Polymerase Chain Reaction Spleen/CYTOLOGY/IMMUNOLOGY Support, Non-U.S. Gov't Th1 Cells/*CYTOLOGY/*IMMUNOLOGY Transcription, Genetic
991230
A99C1077

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .